Callan JMB director Gerald Dial acquires 10,000 shares for $7,620

Callan JMB enters ATM equity sales agreement for up to $5 million stock offering

BRIEF-Callan JMB May Offer Up To $200 Million In Securities

Callan JMB files $250M mixed securities shelf

Callan Jmb Inc - May Offer up to $200 Mln in Securities - SEC Filing

Callan JMB expands $175,000 per month infrastructure engagement

Callan JMB extends public sector infrastructure contract worth about $1.05 million over six months

Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement

Callan Jmb Q1 EPS $(0.59) Down From $(0.32) YoY, Sales $1.106M Down From $1.449M YoY

Callan JMB Q1 FY26 net loss widens 159% to $3.22 million; revenue falls 24% to $1.11 million

Callan JMB announces The Atlas Complex in Alabama

Callan JMB signs partnership agreement with India’s Walker’s Pharmaceuticals for Atlas Complex

Callan Jmb Inc - Intends to Pursue Foreign-Trade Zone Subzone Designation for Atlas Complex

Callan Jmb Inc - Atlas Complex Expected to Bring 250–300 Jobs and Long-Term Capital Investment to Marion

Callan Jmb Inc - Announces Atlas Complex, 150 Acre Campus in Alabama for Pharmaceutical Onshoring

Callan Jmb: Complaint Filed by Eddie Patent Holdings Does Not Impact Operations, Strategic Partnerships, or Ongoing Projects

Callan JMB faces lawsuit filed by Eddie Patent Holdings in Texas federal court

Callan JMB gets Nasdaq notice for falling below $2.5 million equity requirement

Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer

Callan JMB FY25 operating loss widens to $7.0 million; revenue falls to $5.7 million